Thanks for your post Mozz. Not sure if my understanding is right here. Do you mean if we get statistically significant improved (p<0.05) for Pain at WOMAC scores at day53 in PARA_008, no serious AEs, even though secondary endpoints not met, we will still get FDA approved?
The P Value Primer, page-8
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $158.9K | 781.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 198291 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 20781 | 4 |
View Market Depth
| Last trade - 14.31pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |